enVVeno Medical Corp Net Fee Amt
enVVeno Medical Corp (NVNO) had Net Fee Amt of $5.89 thousand as of 2026-08-21, per its S-3 filed 2026-08-21.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-08-21
- 2026-08-21: Net Fee Amt $5.89K.
| Period end | Net Fee Amt |
|---|---|
| 2026-08-21 | $5.89K S-3 · filed 2026-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |